These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7562512)

  • 1. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors.
    Keil GJ; Delander GE
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1387-92. PubMed ID: 7562512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice.
    De Lander GE; Keil GJ
    J Pharmacol Exp Ther; 1994 Feb; 268(2):943-51. PubMed ID: 8114009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM; White TD; Sawynok J
    J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H; Labuz D; Przewłocki R; Przewłocka B
    J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
    Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice.
    Ohsawa M; Nagase H; Kamei J
    J Pharmacol Exp Ther; 1998 Aug; 286(2):780-7. PubMed ID: 9694934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
    Paproski RJ; Visser F; Zhang J; Tackaberry T; Damaraju V; Baldwin SA; Young JD; Cass CE
    Biochem J; 2008 Sep; 414(2):291-300. PubMed ID: 18462193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: effect of inhibitors of equilibrative systems on the content and retention of nucleosides.
    Dagnino L; Paterson AR
    Cancer Res; 1990 Oct; 50(20):6549-53. PubMed ID: 1698538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
    McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
    Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
    Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?
    Welch SP; Dunlow LD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):390-9. PubMed ID: 8229767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
    Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
    Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.